Acute generalised exanthematous pustulosis - DermNet
WEBAcute generalised exanthematous pustulosis, or AGEP, is an uncommon pustular drug eruption characterised by superficial pustules. AGEP is usually classified as a severe cutaneous adverse reaction (SCAR) to a prescribed drug. It is also called toxic pustuloderma. Early signs of acute generalised exanthematous pustulosis
Acute Generalized Exanthematous Pustulosis - StatPearls - NCBI Bookshelf
WEBMay 3, 2023 · Acute generalized exanthematous pustulosis (AGEP) is an adverse cutaneous reaction characterized by sterile pinpoint nonfollicular pustules atop an erythematous background.
Acute generalized exanthematous pustulosis (AGEP) - UpToDate
WEBAug 26, 2024 · Acute generalized exanthematous pustulosis (AGEP) is a rare, acute, severe cutaneous adverse reaction characterized by the development of numerous nonfollicular, sterile pustules on a background of edematous erythema [1-3].
Approach to the patient with pustular skin lesions - UpToDate
WEBNov 9, 2023 · Pustules are skin lesions formed by a collection of leukocytes (predominantly neutrophils) within the epidermis or superficial dermis. Pustular skin lesions can be infectious or inflammatory and should be differentiated from vesicular eruptions.
Acute generalized exanthematous pustulosis - Wikipedia
WEBAcute generalized exanthematous pustulosis (AGEP; also known as pustular drug eruption and toxic pustuloderma) is a rare skin reaction that in 90% of cases is related to medication. AGEP is characterized by sudden skin eruptions that appear on average five days after a medication is started.
Acute Generalised Exanthematous Pustulosis: An Update
WEBAcute generalised exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction and is attributed to drugs in more than 90% of cases. It is a rare disease, with an estimated incidence of 1–5 patients per million per year.
Characteristics, Disease Course, and Outcomes of Acute …
WEBAcute generalized exanthematous pustulosis (AGEP) is a rare, severe cutaneous adverse reaction with an estimated incidence of 1 to 5 cases per million per year. 1 The reaction is defined by acute development of generalized erythema with dozens to hundreds of overlying sterile nonfollicular pustules that begin to resolve after the offending ...
Acute Generalized Exanthematous Pustulosis: Clinical Features ...
WEBAcute generalized exanthematous pustulosis (AGEP) is a rare, acute, severe cutaneous adverse reaction mainly attributed to drugs, although other triggers, including infections, vaccinations, ingestion of various substances, and spider bites, have also been described.
Clinical presentation and management of atypical and recalcitrant …
WEBAcute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction (SCAR) characterized by sterile nonfollicular pustules on an erythematous base that form rapidly after drug exposure.
Acute generalized exanthematous pustulosis (AGEP): A review …
WEBAcute generalized exanthematous pustulosis is a severe cutaneous adverse reaction characterized by the rapid development of nonfollicular, sterile pustules on an erythematous base. It is attributed to drugs in the majority of cases.